Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 204703
Company: XIROMED

Products on ANDA 204703

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL	ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE	0.035MG;1MG	TABLET;ORAL-28	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 204703

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/28/2016	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
04/29/2022	SUPPL-4	Labeling-Package Insert		Label is not available on this site.
08/09/2017	SUPPL-1	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 204703

ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL

TABLET;ORAL-28; 0.035MG;1MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL	ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE	0.035MG;1MG	TABLET;ORAL-28	Prescription	No	AB	204703	XIROMED
KELNOR	ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE	0.035MG;1MG	TABLET;ORAL-28	Prescription	No	AB	076785	BARR
LO-MALMOREDE	ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE	0.035MG;1MG	TABLET;ORAL-28	Prescription	No	AB	209548	NOVAST LABS